EW Q4 2021 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.3B+11.6% YoY

Gross Profit

$1.0B76.6% margin

Operating Income

$362M27.2% margin

Net Income

$335M25.2% margin

EPS (Diluted)

$0.53

QoQ Revenue Growth

+1.5%

Cash Flow

Operating Cash Flow

$374M

Free Cash Flow

$280M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$8.5B

Total Liabilities

$2.7B

Stockholders' Equity

$5.8B

Cash & Equivalents

$863M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.2B	+11.6%
Gross Profit	$1.0B	$897M	+13.6%
Operating Income	$362M	$362M	-0.1%
Net Income	$335M	$310M	+8.3%

Revenue Segments

Transcatheter Heart Valves

$872M66%

Surgical Heart Valve Therapy

$221M17%

Critical Care

$212M16%

Transcatheter Mitral And Tricuspid Therapies

$25M2%

Geographic Segments

UNITED STATES

$740M56%

Europe

$309M23%

Rest of World

$142M11%

JAPAN

$139M10%